Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Jul 01, 2008 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be

LabCorp Announces Availability of OvaSure(TM)

Ovarian Cancer Test For High-Risk Women BURLINGTON, N.C.--(BUSINESS WIRE)--June 23, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) is now offering OvaSure(TM), an Ovarian Cancer Screening test to assess the presence of early stage ovarian cancer in high-risk women.

LabCorp is Scheduled to Present at the 18th Annual Wachovia Nantucket Equity Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--June 23, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer, is scheduled to speak at the 18th Annual Wachovia Nantucket Equity Conference in Nantucket, MA.

LabCorp is Scheduled to Present at the Jefferies 2nd Annual Healthcare Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--June 20, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that David P. King, Chief Executive Officer and Bradford T. Smith, Executive Vice President, Corporate Affairs, are scheduled to speak at the Jefferies 2nd Annual

LabCorp is Scheduled to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--June 9, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer and Bradford T. Smith, Executive Vice President, Corporate Affairs, are scheduled to speak at the Goldman Sachs

LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests

BURLINGTON, N.C. & ROCKVILLE, Md.--(BUSINESS WIRE)--June 5, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH), one of the world's leading clinical trials and genetic testing laboratories, and Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused

LabCorp First Company to Commercially Launch Gene Methylation Test for Prostate Cancer

BURLINGTON, N.C.--(BUSINESS WIRE)--May 16, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) an industry leader in oncology testing, announced the commercial launch of an assay for detecting the presence of key tissue markers in prostate cancer, including the methylated

LabCorp is Scheduled to Present at the Bank of America 2008 Health Care Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--May 12, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer and William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, are scheduled to speak at the Bank of

Laboratory Corporation of America(R) Holdings Announces 2008 First Quarter Results

Strong Operating Results Drive EPS Growth of 16.3% BURLINGTON, N.C.--(BUSINESS WIRE)--April 24, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter ended March 31, 2008. First Quarter Results Net earnings increased to $130.3 million,

LabCorp is Scheduled to Present at the Lehman Brothers 2008 Global Healthcare Conference

BURLINGTON, N.C., Mar 13, 2008 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer and William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, are scheduled to speak at the Lehman